Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 20, 2024Advanced ScienceOpen Access

Meis1 Targets Protein Tyrosine Phosphatase Receptor J in Fibroblast to Retard Chronic Kidney Disease Progression

View Full Paper
Ask AI
Bookmark
Share

Authors

MBMi BaiUniversity College LondonSXShuang XuNorth China University of Science and TechnologyMJMingzhu JiangNanjing Children's Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bai et al. (2024) studied this question.

synapsesocial.com/papers/68e5b8a1b6db64358755125fhttps://doi.org/10.1002/advs.202309754
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Meis1 is specifically upregulated in kidney myofibroblasts during aging and injury but is not required for kidney homeostasis or fibrotic response2018 · 23 citations
  2. 2Development of Small Molecule MEIS Inhibitors that modulate HSC activity2020 · 42 citations
  3. 3Primary sequence determinants responsible for site‐selective dephosphorylation of the PDGF β‐receptor by the receptor‐like protein tyrosine phosphatase DEP‐12002 · 23 citations
  4. 4MEIS1 inhibits clear cell renal cell carcinoma cells proliferation and in vitro invasion or migration2017 · 39 citations
  5. 5Meis1 regulates the metabolic phenotype and oxidant defense of hematopoietic stem cells2012 · 241 citations